What is EyePoint, Inc. 's stock issuance proceeds?

EyePoint, Inc. (EYPT) reported stock issuance proceeds of $166.79M in Q4 2025.

How has EyePoint, Inc. 's stock issuance proceeds changed year-over-year?

EyePoint, Inc. 's stock issuance proceeds increased by 10.1% year-over-year, from $151.52M to $166.79M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

EyePoint, Inc. EYPT Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Merck & Co.MRK

$157M+726%

Regeneron PharmaceuticalsREGN

$163.1M+169%

Ocular TherapeutixOCUL

$294K-93.0%

Kodiak Sciences IncKOD

$922K+644%

HRO

HarrowHROW

$25K+8.7%

Theravance BiopharmaTBPH

$241K+1,105%

Other financials

Income statement

See full

Revenue$696.0K-97.2%

Gross profit$9.8M-30.1%

Operating income-$87.2M-78.6%

Net income-$84.8M-87.7%

EPS (diluted)-$0.99-52.3%

Balance sheet

See full

Cash & equivalents$77.7M-8.7%

Total debt$22.3M-7.3%

Total equity$230.5M-22.8%

Total assets$288.2M-20.5%

Cash flow

See full

Operating cash flow-$80.5M-51.6%

CapEx$997.0K+261%

Free cash flow-$81.5M-52.7%

Valuation

See full

Market cap$1.21B+189%

Enterprise value$1.15B+228%

P/S158.5×+151×

Profitability

See full

Operating margin-3,700.9%-4,042pp

Net margin-3,566.6%-3,874pp

FCF margin-3,565.9%-3,884pp

Returns & leverage

See full

Return on equity-102.7%+1,157pp

Debt / equity0.1×0.0×

Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: EyePoint, Inc. ’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is EyePoint, Inc. 's stock issuance proceeds?: EyePoint, Inc. (EYPT) reported stock issuance proceeds of $166.79M in Q4 2025.
How has EyePoint, Inc. 's stock issuance proceeds changed year-over-year?: EyePoint, Inc. 's stock issuance proceeds increased by 10.1% year-over-year, from $151.52M to $166.79M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.